Bios-Background-Blue.jpg

News & Views

The latest news and developments from BioSymetrics

Featured
PRESS RELEASE: BioSymetrics partners with Ginkgo Bioworks to create innovation network
PRESS RELEASE: BioSymetrics partners with Ginkgo Bioworks to create innovation network
BLOG: The Pheno-Type: Shahrzad Hosseini on her STEM career journey that started in Iran
BLOG: The Pheno-Type: Shahrzad Hosseini on her STEM career journey that started in Iran
PRESS RELEASE: Yolanda Sanchez, ex-GSK R&D Leader, Joins BioSymetrics as Scientific Advisor
PRESS RELEASE: Yolanda Sanchez, ex-GSK R&D Leader, Joins BioSymetrics as Scientific Advisor
PRESS RELEASE: John Baldoni, ex-GSK R&D Leader, Joins BioSymetrics as Strategic Advisor
PRESS RELEASE: John Baldoni, ex-GSK R&D Leader, Joins BioSymetrics as Strategic Advisor
PRESS RELEASE: Deerfield Management and BioSymetrics partner to discover and develop novel therapeutics
PRESS RELEASE: Deerfield Management and BioSymetrics partner to discover and develop novel therapeutics
BLOG: The Pheno-Type: Calum MacRae on his “hopelessly diffuse” career in science and medicine
BLOG: The Pheno-Type: Calum MacRae on his “hopelessly diffuse” career in science and medicine
BLOG: The Pheno-Type: Dave Kokel on Serendipity and Science, plus Zebrafish
BLOG: The Pheno-Type: Dave Kokel on Serendipity and Science, plus Zebrafish
NEWS: How Will Advanced Computing Technologies Catapult Medtech Into The Future?
NEWS: How Will Advanced Computing Technologies Catapult Medtech Into The Future?
BLOG: What is the Phenograph? Learn About our Map for Connecting Phenotypes to Genes to Drugs
BLOG: What is the Phenograph? Learn About our Map for Connecting Phenotypes to Genes to Drugs
NEWS: Sema4, BioSymetrics Partner on Multiomic Drug Discovery
NEWS: Sema4, BioSymetrics Partner on Multiomic Drug Discovery
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
NEWS: European Biopharmaceutical Review: Op-Ed on Phenomics, the Future of Drug Discovery
NEWS: European Biopharmaceutical Review: Op-Ed on Phenomics, the Future of Drug Discovery
BLOG: Interview with VP of Data Science Research on COVID-19 Studies with Humanigen
BLOG: Interview with VP of Data Science Research on COVID-19 Studies with Humanigen
NEWS: GEN: The Future of Biotech in an Artificially Intelligent World
NEWS: GEN: The Future of Biotech in an Artificially Intelligent World
MEDIA ALERT: BioSymetrics to Present Phenomics-Driven Approach to Drug Discovery at Biotech Showcase 2022
MEDIA ALERT: BioSymetrics to Present Phenomics-Driven Approach to Drug Discovery at Biotech Showcase 2022
PRESS RELEASE: BioSymetrics Expands Leadership Team to Support Rapid Growth
PRESS RELEASE: BioSymetrics Expands Leadership Team to Support Rapid Growth
NEWS: Nature: Tapping into the drug discovery potential of AI
NEWS: Nature: Tapping into the drug discovery potential of AI
Binary Classification Metrics
Binary Classification Metrics
Feature Selection Using Contingent AI: Going Beyond Mutual Information
Feature Selection Using Contingent AI: Going Beyond Mutual Information
Calculating Mortality from COVID-19
Calculating Mortality from COVID-19

 

MEDIA / EVENT INQUIRIES

Denise Johnston

denise@biosymetrics.com